The role of nuclear morphometry in prediction of prognosis for rhabdomyosarcoma in children

Histopathology

Volumn 45, Issue 4, 2004, Pages 352-359

  Kazanowska, Bernarda ^a   Jelen, M ^a   Reich, A ^a   Tarnawski, W ^b   Chybicka, A ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Children; Nuclear morphometry; Rhabdomyosarcoma

Indexed keywords

ARTICLE; CANCER SURVIVAL; CELL NUCLEUS; CELL TYPE; CHILD; CHILDHOOD CANCER; DIAGNOSTIC TEST; EMBRYONAL RHABDOMYOSARCOMA; EVENT FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; NUCLEAR MORPHOMETRY; OUTCOMES RESEARCH; PATIENT SELECTION; POLAND; PRIORITY JOURNAL; PROGNOSIS; RHABDOMYOSARCOMA; STAINING; TISSUE SECTION; TUMOR BIOPSY; UNDIFFERENTIATED CARCINOMA; UNDIFFERENTIATED RHABDOMYOSARCOMA;

CELL NUCLEUS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFANT; MALE; PROGNOSIS; RHABDOMYOSARCOMA; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 7244234145     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2004.01948.x     Document Type: Article

References (22)

1. Harms D, Schmidt D. Spezielle Tumoren des Kindesalters (Solid tumors of childhood-immunochemistry, diagnosis and differentiation). Verh. Dtsch Ges. Path. 1986; 70; 190-204.
2. Calllaud JM, Gerard-Marchand R, Mardsen HB et al. Histological classification of childhood rhabdomyosarcoma: a report from International Society of Pediatric Oncology Panel. Med. Pediatr. Oncol. 1989; 17; 391-400.
3. Koscielniak E, Harms D, Henze G et al. Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J. Clin. Oncol. 1999; 17; 3706-3719.
4. Baker BR, Anderson JR, Link MP et al. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. J. Clin. Oncol. 2000; 18; 2427-2434.
5. Choong PPM, Akerman M, Willen H et al. Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation-a marker of metastasis? APMIS 1994; 102; 915-924.
6. Sorensen PHB, Lynch JC, Qualman SJ et al. PAX3-FKHR and PAX7-FKBR gene fusions are prognostic indicators in the alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. J. Clin. Oncol. 2002; 20; 2672-2679.
7. Pappo AS, Crist WM, Newton W et al. Tumor cell DNA content predicts outcome in children and adolescents with clinical group III embryonal rhabdomyosarcoma. Proceedings, ASCO 1993; 12; 411.
8. Diamond DA, Berry SJ, Jewett HJ, Eggleston JC, Coffey DS. A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness. J. Urol. 1982; 128; 729-734.
9. Tosi P, Luzi P, Baak JP et al. Nuclear morphometry as an important prognostic factor in stage I renal cell carcinoma. Cancer 1986; 58; 2512-2518.
10. Hogberg T, Wang G, Risberg B et al. Nuclear morphometry: a strong prognostic factor for survival after secondary surgery in advanced ovarian cancer. Int. J. Gynecol. Cancer 1992; 2; 198-206.
11. Partin AW, Gearhart JP, Leonard MP et al. The use of nuclear morphometry to predict prognosis in pediatric urologic malignancies: a review. Med. Ped. Oncol. 1993; 21; 222-229.
12. Leonard MP, Partin AW, Epstein JI, Jeffs RD, Gearhart JP. Nuclear morphometry as a prognostic indicator for genitourinary rhabdomyosarcoma: a preliminary investigation. J. Urol. 1990; 144; 1222-1225.
13. Noguchi S, Tamiya S, Nagoshi M, Suita S, Fukuda T, Tsuneyoshi M. Nuclear morphometry and the MIB-1 index in rhabdomyosarcoma. Mod. Pathol. 1996; 9; 253-259.
14. Callaghan RC, Carda C, Peydro-Olaya A, Triche T, Llombart-Bosch A. Small round cell tumors of bone and soft tissue. A morphometric and stereometric comparative analysis of 119 cases. Anal. Quant. Cytol. Histol. 1995; 17; 374-382.
15. Brahmi U, Rajwanshi A, Joshi K et al. Automated nuclear image morphometry on fine needle aspiration smears of malignant round cell tumors. Anal. Quant. Cytol. Histol. 2001; 23; 287-290.
16. Cavazzana AO, Schmidt D, Ninfo V et al. Spindle cell rhabdomyosarcoma: a prognostically favorable variant of rhabdomyosarcoma. Am. J. Surg. Pathol. 1992; 16; 229-235.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J. Am. Stat. Assoc. 1958; 53; 457-481.
18. Peto R, Pike MC, Armitage P et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br. J. Cancer 1977; 35; 1-39.
19. Seidal T, Kindblom LG. The ultrastructure of alveolar and embryonal rhabdomyosarcoma. A correlative light and electron microscopic study of 17 cases. Acta Pathol. Microbiol. Immunol. Scand. A 1984; 92; 231-239.
20. Lombardi L, Pilotti S. Ultrastructural characterization of poorly differentiated rhabdomyosarcomas. Ultrastruct. Pathol. 1993; 17; 669-680.
21. Breneman JC, Lyden E, Pappo AS et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma - a report from the Intergroup Rhabdomyosarcoma Study IV. J. Clin. Oncol. 2003; 21; 78-84.
22. Multizentrische Therapiestudie zur Behandlung von Kindern und Jugendlichen mit Weichteilsarkommen. Cooperative Weichteilsarkomstudie CWS-96. Stuttgart: Protokoll, 1996.